News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events – mechanisms and therapeutic intervention
Diego A. Díaz García/X
Jun 13, 2025, 03:49

Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events – mechanisms and therapeutic intervention

Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X:

“Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention. The gut microbiota plays a key role in irAE development, especially ICI-induced colitis. Microbial biomarkers and therapies like FMT offer new hope for managing irAEs.”

Title: Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention

Authors: Ya-Qi Gao, Yong-Jie Tan, Jing-Yuan Fang

Read the Full Article.

Diego A. Díaz García

More posts featuring Diego A. Díaz García.

cancer Diego A. Díaz García Jing-Yuan Fang OncoDaily Oncology Ya-Qi Gao Yong-Jie Tan
Special Coverage
Insight
Jun 13, 2025, 04:29
MD Anderson Research Highlights
Drugs
Jun 13, 2025, 04:16
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Insight
Jun 13, 2025, 03:49
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events - mechanisms and therapeutic intervention
Oncolibrary
Jun 13, 2025, 03:18
Etiology: Understanding the Causes and Origins of Disease
Insight
Jun 12, 2025, 19:31
Amar Kishan: UCLA Launches ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT
Insight
Jun 12, 2025, 19:16
Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC
Insight
Jun 12, 2025, 19:07
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Blog
Jun 12, 2025, 18:57
Edward Christopher Dee and Layal Al Mahmasani Highlighted Participation in Inaugural Global Oncology Trainee Track at MSK
Blog
Jun 12, 2025, 18:40
Register for the 2nd National Cancer Summit - National Cancer Institute of Kenya
Blog
Jun 12, 2025, 18:30
ESMO Daily Reporter Interviewed Paolo Tarantino on ADCs in Breast Cancer Care
Insight
Jun 12, 2025, 18:22
Bruna Pellini: Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative sqNSCLC
Insight
Jun 12, 2025, 18:16
Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients